Elite in Stroke

Yannick Bejot

Dijon, FR 
Elite in Stroke
Dijon, FR 
OverviewLocationsClinical Research

Overview

Yannick Bejot practices in Dijon, France. Mr. Bejot is rated as an Elite expert by MediFind in the treatment of Stroke. His top areas of expertise are Stroke, Transient Ischemic Attack (TIA), Atrial Fibrillation, Thrombectomy, and Patent Foramen Ovale Repair.

His clinical research consists of co-authoring 309 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 240 articles and participated in 1 clinical trial in the study of Stroke.

Gender
Male

Locations

Dijon, France
Other Locations
CHRU Gui de Chauliac
Montpellier, France
Bourgogne, France
Lille, France
Caen, France
INSERM 894, INSERM 1148, University Paris Est Creteil, INSERM 894, INSERM 1191, Dijon Stroke Registry, EA 7460, INSERM 1059, INSERM 1078, Lens, France
Besancon, 25000, France
Saint-maurice-en-valgodemard, France
Lyon, France
Paris, France
France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Prevalence of Strokes Secondary to a Reversible Cerebral Vasoconstriction Attributable to Cannabis Consumption in Young Subjects (≤ 45 Years) Hospitalized for an Ischaemic Stroke
Prevalence of Strokes Secondary to a Reversible Cerebral Vasoconstriction Attributable to Cannabis Consumption in Young Subjects (≤ 45 Years) Hospitalized for an Ischaemic Stroke
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2024
Intervention Type: Other
Study Phase: Not Applicable
A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion
A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion
Enrollment Status: Completed
Publish Date: January 24, 2024
Intervention Type: Drug
Study Drugs: Alteplase, Acetylsalicylic acid
Study Phase: Phase 3
View 1 Less Clinical Trial

309 Total Publications

Systematic Genetic Assessment in Young Patients With Cryptogenic Stroke: The ES-EASY project.
Systematic Genetic Assessment in Young Patients With Cryptogenic Stroke: The ES-EASY project.
Journal: Stroke
Published: September 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bejot's expertise for a condition
ConditionClose
View All 65 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile